357 related articles for article (PubMed ID: 17043122)
21. Comparison of the Etest and microdilution method for antifungal susceptibility testing of Cryptococcus neoformans to four antifungal agents.
Aller AI; Martín-Mazuelos E; Gutiérrez MJ; Bernal S; Chávez M; Recio FJ
J Antimicrob Chemother; 2000 Dec; 46(6):997-1000. PubMed ID: 11102421
[TBL] [Abstract][Full Text] [Related]
22. A novel dodecapeptide from a combinatorial synthetic library exhibits potent antifungal activity and synergy with standard antimycotic agents.
Duggineni S; Srivastava G; Kundu B; Kumar M; Chaturvedi AK; Shukla PK
Int J Antimicrob Agents; 2007 Jan; 29(1):73-8. PubMed ID: 17156978
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of antifungal combination against Cryptococcus spp.
Reichert-Lima F; Busso-Lopes AF; Lyra L; Peron IH; Taguchi H; Mikami Y; Kamei K; Moretti ML; Schreiber AZ
Mycoses; 2016 Sep; 59(9):585-93. PubMed ID: 27135278
[TBL] [Abstract][Full Text] [Related]
24. In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans.
Barchiesi F; Giacometti A; Cirioni O; Arzeni D; Silvestri C; Kamysz W; Abbruzzetti A; Riva A; Kamysz E; Scalise G
Peptides; 2007 Aug; 28(8):1509-13. PubMed ID: 17698253
[TBL] [Abstract][Full Text] [Related]
25. Combined in vitro activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans and Candida albicans.
Chen HH; Liushih RN; Hsieh WC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 May; 15(2):106-12. PubMed ID: 7047097
[TBL] [Abstract][Full Text] [Related]
26. Serotypes of clinical cerebrospinal fluid Cryptococcus neoformans isolates from southern Taiwan and their in vitro susceptibilities to amphotericin B, fluconazole, and voriconazole.
Chang WN; Huang CR; Lei CB; Lee PY; Chien CC; Chang HW; Chang CS; Lu CH
Jpn J Infect Dis; 2004 Jun; 57(3):113-5. PubMed ID: 15218221
[TBL] [Abstract][Full Text] [Related]
27. In-vitro interactions of itraconazole with flucytosine against clinical isolates of Cryptococcus neoformans.
Barchiesi F; Gallo D; Caselli F; Di Francesco LF; Arzeni D; Giacometti A; Scalise G
J Antimicrob Chemother; 1999 Jul; 44(1):65-70. PubMed ID: 10459811
[TBL] [Abstract][Full Text] [Related]
28. Susceptibility of clinical isolates of Cryptococcus neoformans to amphotericin B using time-kill methodology.
Pappalardo MC; Szeszs MW; Martins MA; Baceti LB; Bonfietti LX; Purisco SU; Baez AA; Melhem MS
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):146-51. PubMed ID: 19345042
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of in vitro antifungal activity of ditiocarb sodium.
Allerberger F; Roberts G; Reisinger E; Dierich MP
Arzneimittelforschung; 1991 Apr; 41(4):443-8. PubMed ID: 1650228
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of amphotericin B and flucytosine against fluconazole-resistant Candida inconspicua clinical isolates.
Majoros L; Kardos G; Feiszt P; Szabó B
J Antimicrob Chemother; 2005 Jul; 56(1):253-4. PubMed ID: 15911550
[No Abstract] [Full Text] [Related]
31. Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine.
Espinel-Ingroff A; Chowdhary A; Cuenca-Estrella M; Fothergill A; Fuller J; Hagen F; Govender N; Guarro J; Johnson E; Lass-Flörl C; Lockhart SR; Martins MA; Meis JF; Melhem MS; Ostrosky-Zeichner L; Pelaez T; Pfaller MA; Schell WA; Trilles L; Kidd S; Turnidge J
Antimicrob Agents Chemother; 2012 Jun; 56(6):3107-13. PubMed ID: 22391546
[TBL] [Abstract][Full Text] [Related]
32. [Research in vitro on the anticryptococcal effects of various steroid hormones alone or in combination with antifungal agents].
Piersantelli N; Robert L; Carlevaro C
Pathologica; 1976; 68(985-986):547-60. PubMed ID: 799294
[No Abstract] [Full Text] [Related]
33. In vitro activity of amphotericin B and itraconazole in combination with flucytosine, sulfadiazine and quinolones against Exophiala spinifera.
Vitale RG; Afeltra J; de Hoog GS; Rijs AJ; Verweij PE
J Antimicrob Chemother; 2003 May; 51(5):1297-300. PubMed ID: 12697648
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the in vitro activity of amphotericin B by time-kill curve methodology against large and small capsulate C. neoformans isolates.
Córdoba S; Afeltra J; Vitale RG
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):260-2. PubMed ID: 21917396
[TBL] [Abstract][Full Text] [Related]
35. Antifungal susceptibility of Cryptococcus neoformans and Cryptococcus gattii isolates from decayed wood of trunk hollows of Ficus religiosa and Syzygium cumini trees in north-western India.
Khan ZU; Randhawa HS; Kowshik T; Chowdhary A; Chandy R
J Antimicrob Chemother; 2007 Aug; 60(2):312-6. PubMed ID: 17553813
[TBL] [Abstract][Full Text] [Related]
36. Identification of a novel antifungal nonapeptide generated by combinatorial approach.
Kumar M; Chaturvedi AK; Kavishwar A; Shukla PK; Kesarwani AP; Kundu B
Int J Antimicrob Agents; 2005 Apr; 25(4):313-20. PubMed ID: 15784311
[TBL] [Abstract][Full Text] [Related]
37. Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
Barchiesi F; Schimizzi AM; Najvar LK; Bocanegra R; Caselli F; Di Cesare S; Giannini D; Di Francesco LF; Giacometti A; Carle F; Scalise G; Graybill JR
Antimicrob Agents Chemother; 2001 May; 45(5):1355-9. PubMed ID: 11302795
[TBL] [Abstract][Full Text] [Related]
38. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and
Rossi SA; de Oliveira HC; Agreda-Mellon D; Lucio J; Mendes-Giannini MJS; García-Cambero JP; Zaragoza O
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31988099
[TBL] [Abstract][Full Text] [Related]
39. [Pulmonary cryptococcosis treated by combination therapy of fluconazole plus flucytosine].
Tanaka K; Kohno S; Maesaki S; Mitsutake K; Miyazaki H; Miyazaki T; Tomono K; Kaku M; Koga H; Hara K
Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Dec; 31(12):1528-33. PubMed ID: 8121088
[TBL] [Abstract][Full Text] [Related]
40. Isolates of Cryptococcus neoformans serotype A or D from cerebrospinal fluid resistant to 5-fluorocytosine.
Arsic V; Mitrovic S; Kranjcic-Zec I; Dzamic A
J Chemother; 1995 Nov; 7 Suppl 4():90-2. PubMed ID: 8904119
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
